Virginia Commonwealth University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Virginia Commonwealth University sits in the top decile of US sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count).
Virginia Commonwealth University: 558 sponsored US clinical trials, 77 recruiting.
Virginia Commonwealth University sponsors 558 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 380 completed. 35 of these trials are in Phase 3-4 (later-stage) and 145 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Virginia Commonwealth University ranks in the top decile of sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
380 of 462 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
558 total, page 4 of 12
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
NCT05263492
Managing Distress in Malignant Brain Cancer
NCT05087095
Entertainment Media to Deliver Educational Messages About Mammography in Saudi Arabia
NCT05176405
Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy
NCT05280730
Bringing Education Through Technology, Empathic Listening, and Research
NCT05214118
Exploring the Familial Reach of Adolescent Obesity Treatment
NCT05780970
Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health
NCT05199480
An Integrative Model for Palliative Care in End-Stage Liver Disease
NCT05238779
A Pilot Study to Examine the Impact of a Therapy Dog Intervention on Loneliness and Related Health Outcomes in Vulnerable Populations
NCT05089201
Understanding Genetic Risk for Alcohol Use Disorder
NCT05143073
Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video
NCT04476654
Recovery Sleepers: A Pilot Study of a Sleep Health Intervention for College Students in Recovery
NCT05114577
Multi-level Determinants of Implementation and Sustainment in the Education Sector
NCT04430010
The Acute Effect of Vaping on Food Intake
NCT04219189
Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms
NCT04988321
Personalized Feedback Programs for College Students
NCT04975191
Use of Stress Inoculation Training in Medical Education
NCT04199221
RHWP Prescription Produce Plan
NCT04995237
Effect of Clear Aligner Attachment Design on Extrusion of Maxillary Lateral Incisors
NCT04968353
Understanding Variability in Behavioral Weight Loss Treatment Response in Young Women (Ready SET Health)
NCT04875091
Virginia Commonwealth University Stress Reduction Study
NCT04190030
Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
NCT03883217
SCH: Context-aware Freezing of Gait Mitigation in Real-world Setting
NCT04746846
CBT for Insomnia in Primary Brain Tumor Patients
NCT04919993
Effects of an External Oral Irrigation Device on Patients With Dry Mouth
NCT04901507
Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder
NCT04818086
The Impact of Vaping Ethanol in the Evaluation of Impairment
NCT03826303
Efficient Anterior Shoulder Ultrasound Reduction Multicenter Prospective Randomized Trial
NCT04820491
A Novel Approach to Reducing Adiposity Among Young Men
NCT04267263
Bundle Consent and Expectation Setting in Pediatric Intensive Care Unit
NCT04697173
Assessing Electronic Cigarette Nicotine Flux
NCT04378907
Effects of E-Cigarette Nicotine Content in Smokers (Nicotine Flux Study)
NCT04332926
SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)
NCT04344184
Managing Cancer and Living Meaningfully
NCT04646213
Netflix Streaming Services in the Operating Room During Total Knee Replacement - a Feasibility Study
NCT04469881
The Effect of Brain Anatomy on the Efficacy of Brain Stimulation Therapy
NCT04586387
Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support
NCT04577131
The Effect of Local Anesthesia on Control of Intraoperative Physiologic Parameters and Post Operative Comfort
NCT04500158
Energy Metabolism in Thyroidectomized Patients
NCT04782856
Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis
NCT04017936
Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use Disorder
NCT04502589
"Mamma Mia" for Perinatal Health and Wellness
NCT04300894
Mindfulness in the OR
NCT04515667
Enhanced Care Planning for Patients With Multiple Chronic Conditions
NCT03885401
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
NCT04463004
Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy
NCT04468230
Screening and Management of Unhealthy Alcohol Use in Primary Care
NCT04248023
Investigating the Effect of Stochastic Resonance Vibration on Gait and Balance and Upper Extremity Function in Children With Cerebral Palsy
NCT04388787
Impact of a LCD on Metabolic Inflexibility and Cardiovascular Risk in Liver Transplant Patients
NCT04145427
Expand Your Horizon: An Online Writing Intervention for Women
NCT04146792
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 65 |
| Phase 3 | 13 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the Virginia Commonwealth University pipeline
77 recruiting of 558 indexed (14% open); 380 completed (68%).
Phase mix: 35 late (III/IV) vs 145 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Virginia Commonwealth University: open-pipeline peers nationwide
Peers matched on 558 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 558 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Ohio State University · 552 trials · 21% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Lindenwood University · 14% recruiting · 29 trials
- BeiGene · 14% recruiting · 65 trials
- Reproductive Medicine Associates of New Jersey · 14% recruiting · 51 trials
- University of Cincinnati · 14% recruiting · 245 trials
Related
What to do with this Virginia Commonwealth University page
558 registered trials is a research-attention snapshot, not an endorsement of Virginia Commonwealth University or any single study.
- 77 of Virginia Commonwealth University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Virginia Commonwealth University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Virginia Commonwealth University pipeline card: 558 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.